HER2-EXPRESSING SOLID TUMORS
Clinical trials for HER2-EXPRESSING SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2-EXPRESSING SOLID TUMORS trials appear
Sign up with your email to follow new studies for HER2-EXPRESSING SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug MT-304 tested in patients with advanced HER2 cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called MT-304, alone or with another drug (nivolumab), in adults with advanced HER2-expressing solid tumors. The main goals are to check safety and find the best dose. About 60 participants will receive the treatment every two to four weeks…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
Gene therapy breakthrough targets HER2 cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new gene therapy called VNX-202 for people with HER2-positive solid tumors. The study aims to see if the treatment is safe and can shrink tumors or slow cancer growth. It involves 27 adults whose cancer has not responded to standard treatments or wh…
Matched conditions: HER2-EXPRESSING SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC